Navigation Links
109 Medicines and Vaccines Now in Development for HIV/AIDS
Date:12/1/2008

or Disease Control and Prevention estimates that more than 1 million Americans were living with HIV infection at the end of 2006.

From 2000 to 2007, America's pharmaceutical research companies contributed more than $9.2 billion to improve health care in the developing world, according to the International Federation of Pharmaceutical Manufacturers & Associations.

The projects they supported included building clinics to treat patients with HIV/AIDS, education and prevention programs, initiatives to prevent mother-to-child transmission of HIV, and donations of medicines for AIDS and related diseases. A number of companies also provide AIDS drugs at reduced prices in many countries.

"With HIV/AIDS medicines, a disease that was once a virtual death sentence can now be controlled and treated as if it were a chronic disease," adds Tauzin. "And the new medicines our scientists are working on right now bring hope for even more promising results in the future."

"While researchers are making exciting progress in the search for new treatments for HIV/AIDS, these efforts are wasted if the medicines that are developed don't get to the patients who need them," said Senior Vice President Ken Johnson.

Help is available to patients in need through the Partnership for Prescription Assistance (PPA), a program sponsored by America's pharmaceutical research companies. To date, the PPA has helped more than 5 million patients nationwide. Since its launch in April 2005, the PPA bus tour has visited all 50 states and more than 2,000 cities.

To read the report Medicines in Development for HIV/AIDS 2008 on the PhRMA Website, go to: http://www.phrma.org

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biote
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Partnership for Safe Medicines Arms Public Against Counterfeit Drugs
2. More Than 2,000 New Medicines in Development for Older Americans
3. GPhA Congratulates President-Elect Barack Obama and New Congress and Urges Action on Increasing Access to Generic -- and Biogeneric -- Medicines
4. Safe New Childrens Medicines Launched for Cough, Cold and Flu Season
5. Older adults can take medicines more safely and effectively by charting their daily routines
6. Complementary medicines can help mild depression and premenstrual syndrome
7. Iowa Educators Prepare to Teach High School Students How Medicines Are Made
8. Launch of help2getbetter.com Provides Convenience and Portability to Household Medicines
9. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
10. Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake
11. AmeriCares Ships Medicines and Medical Supplies to Earthquake Victims in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... April 24, 2014 Pregnant immigrants from Sub-Saharan ... increased monitoring during pregnancy, according to new research ... today in the British Journal of Obstetrics ... and eclampsia rates among immigrants and native-born women ... (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and ...
(Date:4/23/2014)... at the National Institute of Arthritis and Musculoskeletal and ... of the Ross Prize in Molecular Medicine, conferred by ... . The award will be given on June 9 ... followed by scientific presentations by Dr. O,Shea and other ... of Health. , The award, which includes a $50,000 ...
(Date:4/23/2014)... report that rats exposed to high-energy particles, simulating conditions ... show lapses in attention and slower reaction times, even ... ranges. , The cognitive impairments which affected a ... appear to be linked to protein changes in ... to hold true in humans, suggest it may be ...
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
(Date:4/23/2014)... predict which patients might suffer potentially fatal side-effects from ... assesses brain scans using pattern recognition software similar to ... been developed by researchers at Imperial College London. Results ... which used the software are published in the journal ... 15 million people each year worldwide. Ischemic strokes are ...
Breaking Medicine News(10 mins):Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3
... received nearly $1 million from the U.S. Department of ... green healthy housing. , The funding was made available ... , UIC researchers will evaluate the health and monetary ... housing into green, affordable, healthy housing. , At a ...
... RN StaffingSILVER SPRING, Md., May 7 Leaders and members ... efforts to secure passage of landmark legislation --reintroduced last night ... RN staffing ratios the law of the land. "As ... better gift for RNs and their patients than the assurance ...
... /PRNewswire/ -- The AANS/CNS Section on Tumors ... BrainLAB Community Neurosurgery Award. Eric Nussbaum, MD, from Minneapolis, ... Results and Complications of the Middle Fossa Approach for ... presented with the award during the 2009 AANS Annual ...
... 7 PARI Pharma GmbH received an Orphan Drug ... positive recommendation by the EMEA for inhaled PARI Tobramycin ... This is the second ODD designation that PARI ... drug pipeline; the first ODD was granted for PARI,s ...
... 2009 In a letter to the Editor of the ... by Elsevier, S. Lefebvre and J.S. Weese from the University ... MRSA and C.difficile could be passed between pet ... C. difficile may have been transferred to the ...
... a considerable number of people worldwide. Although the introduction ... revolutionized treatment of peptic ulcers and other gastrointestinal disorders, ... It has been shown that long term use of ... Relapses of the malady, ineffectiveness of different drug regimens ...
Cached Medicine News:Health News:UIC receives $1M HUD grant to study green healthy housing 2Health News:UAN Hails Reintroduction of Federal RN Staffing Ratio Bill and Vows to Work for Passage 2Health News:AANS/CNS and BrainLAB Announce Winner of 2009 BrainLAB Community Neurosurgery Award 2Health News:AANS/CNS and BrainLAB Announce Winner of 2009 BrainLAB Community Neurosurgery Award 3Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 3Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 4Health News:Transmission of MRSA and Clostridium difficile through dogs 2Health News:A potential anti-ulcer herb medicine: Rocket 'Eruca sativa' 2
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide ... from the Journal of Drugs in Dermatology ... Conference (ODAC). The event is January 17-20, 2014, at the Omni ... . The ODAC is a distinguished ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
... PCYC ) today reported financial results for its fiscal year ... During the fiscal year ended June 30, 2010, total revenue recognized ... fiscal year ended June 30, 2009.  The GAAP net loss reported ... or $0.31 per share. This compares to a GAAP net loss ...
... Sept. 13 Amgen (Nasdaq: AMGN ) will ... 2010, at the St. Regis New York in New York ... Ph.D., vice president of Global Development, for Amgen, will present ... available over the Internet and can be accessed from Amgen,s ...
Cached Medicine Technology:Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 2Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 3Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 4Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 5Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 6Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 7Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 8Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 9Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 10Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 11Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 12Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 13Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 14
... the Attain Prevail's steerable tip, along with ... to obtain the curve you need, when ... improved visualization of the cardiac venous anatomy, ... Telescoping - Adjust curve and reach ...
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
... Mosaic, the third generation tissue valve from ... tissue valve available. The Mosaic valve builds ... and is an excellent choice for patients ... with a tissue valve. For more than ...
... Hancock Standard Mitral bioprosthesis is ... predictable results based on 25 ... long-term performance makes it an ... mitral valve replacement--particularly elderly patients ...
Medicine Products: